🎉 Finosauras is now  SarasRead more
Bafna Pharmaceuticals Ltd logo

Bafna Pharmaceuticals Ltd - Share Price Target 2026

(NSE: BAFNAPH)

Sector: Healthcare

Market Cap: 412.33 Cr

168.09

-

203.87

Target Price Range

122.00

-5.07 (-4.16%)

CMP

Bullish

As on 19 Jan 2026, 03:30 pm

Market Trends

Based on 6 technical indicators.
Bullish3
Bearish1
Neutral2
Agg. Profit Potential53.15%
Agg. Risk 5.51%

Last updated on: 19/01/2026, 3:30 pm

Returns

PeriodReturn %
1 Month-22.95
3 Months21.13
1 Year49.27
5 Years-21.09

Last updated on: 04/12/2025, 9:30 AM

Institutional Holdings

InstitutePercentageNo. of Shares
M7 GLOBAL FUND PCC-AERION3.21%760,059
M7 GLOBAL FUND PCC - CELL DEWCAP FUND3.12%737,158
ZEAL GLOBAL OPPORTUNITIES FUND3.01%712,586

Last updated on: 9/30/2025, 12:00:00 AM

Loading technical analysis...

Fundamental Data

Fundamental Analysis

P/E Ratio

46.98

P/B Ratio

4.52

PEG Ratio

-0.98

ROE

5.01%

EPS

3.71

Dividend Yield

N/A

Market Cap

412.33 Cr

Sector

N/A

Last Updated: 2 Jan 2026, 02:30 pm

Peer Comparison

CompanySentimentTarget PriceUpside

About : Bafna Pharmaceuticals Ltd.

Incorporated Year

1995

City and State

Chennai, Tamil Nadu

Listing Date

Director's Name

Vinayak Dinesh Dendukuri

Revenue

145.86 Cr

Net Profit

4.15 Cr